San Antonio, TX, United States of America

Christopher Ronald Rathbone

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Arteriocyte Inc.. Active years: 2026.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christopher Ronald Rathbone: Innovator in Wound Care Technology

Introduction

Christopher Ronald Rathbone is an accomplished inventor based in San Antonio, TX (US). He has made significant contributions to the field of medical technology, particularly in wound care. His innovative approach focuses on enhancing the effectiveness of dressings used in various medical applications.

Latest Patents

Rathbone holds a patent for "Dressings comprising platelet lysate." This invention involves a dressing that includes a delivery vehicle and platelet lysate. The dressing can also incorporate an antimicrobial agent, a hemostatic agent, and a binder. It is designed to expedite hemostasis, improve antimicrobial activity, minimize fluid loss, and accelerate wound healing when applied to a wound. This dressing is particularly useful in military in-theater medical care and for conditions such as diabetic foot ulcers, among other applications.

Career Highlights

Christopher Rathbone is associated with Arteriocyte Inc., a company that specializes in advanced medical technologies. His work at Arteriocyte has allowed him to focus on developing innovative solutions that address critical healthcare challenges.

Collaborations

Rathbone collaborates with talented professionals in his field, including Vivek Prabhakar Raut and Meghan Elizabeth Samberg. These collaborations enhance the development of cutting-edge medical technologies.

Conclusion

Christopher Ronald Rathbone is a notable inventor whose work in wound care technology has the potential to significantly impact patient outcomes. His innovative dressing design exemplifies the importance of advancements in medical treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…